Purchase Order 75D30121P10261
Award Date 12/29/20
Potential Completion Date 12/26/21
Potential Value $28M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burlington, NC, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $13,031,850.00 firm-fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (LabCorp) for genomic sequencing services. The contract has an ultimate completion date of May 14, 2022 and was awarded on December 26, 2021. LabCorp is a leading global life sciences company that provides diagnostic information services. They have extensive experience contracting with the federal government, including through their...
- This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...
- Laboratory Corporation of America Holdings, doing business as Labcorp, has been awarded a definitive contract valued at $4.19 million by the Centers for Disease Control and Prevention to conduct an Assessment of SARS-CoV-2 Seroprevalence and Immune Responses. The contract is a firm fixed price agreement for Labcorp to perform seroprevalence studies and analyze immune responses to COVID-19 in Burlington, North Carolina over an eight-month period ending in February 2022. No subcontractors or set...
- Laboratory Corporation of America Holdings has been awarded a $533,990 firm fixed price delivery order by the Centers for Disease Control and Prevention in Pittsburgh for surge serology testing in support of coronavirus COVID-19 efforts. The contract runs from January 14, 2021 through April 26, 2021 and will see Laboratory Corporation perform serology testing services from its location in Burlington, North Carolina. No subcontractors or set aside designations were specified. This delivery...
- The U.S. Department of the Army Medical Command awarded a firm fixed price delivery order contract for $300,074.75 to Laboratory Corporation of America (LabCorp), a leading global life sciences company, for clinical reference laboratory testing services. This contract was not set aside and does not appear to be part of a larger contracting vehicle. LabCorp has been awarded numerous federal contracts to provide medical laboratory testing and analysis services in support of government healthcare...
- This is a firm fixed-price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Laboratory Corporation of America (Labcorp), a leading global life sciences company. The $164,894 contract is for "NEXTGEN SEQUENCING AND OMICS SERVICES" with an ultimate completion date of August 30, 2017. Labcorp, the prime contractor, has a strong track record of providing comprehensive clinical laboratory services to federal agencies, including...
- This is a $1,974,948.75 definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America Holdings (LabCorp), a global life sciences company. The contract is for medical laboratory testing and analysis services, including clinical diagnostics, reference laboratory testing, genetic testing, and specialized medical analyses. The contract does not have a set-aside designation, indicating LabCorp competed in an open market procurement....
- The Centers for Disease Control and Prevention (CDC) awarded a $1.249 million firm fixed price delivery order contract to Laboratory Corporation of America Holdings (LabCorp) for surge serology testing. Under the contract, LabCorp will provide serology testing services to the CDC in Burlington, North Carolina through December 2020 to support the agency's COVID-19 response efforts. No subcontractors or set aside designations were identified. The CDC is a component of the U.S. Department of Health...
- This is a delivery order awarded by the Department of the Army Medical Command to Laboratory Corporation of America (LabCorp), a leading global life sciences company, to provide COVID-19 clinical reference lab testing services. The firm fixed price contract, with a potential value of $349,092.19, has a completion date of February 28, 2021. LabCorp has extensive experience providing medical laboratory testing and analysis services to federal agencies, including the Department of Veterans Affairs,...
- The Centers for Disease Control and Prevention (CDC) awarded Laboratory Corporation of America (Labcorp) a definitive firm fixed-price contract valued at $91.69M for COVID-19 laboratory testing services, with an ultimate completion date of April 22, 2025. The contract, which was awarded on May 16, 2022, operates as a child contract without small business set-aside provisions and is performed at Labcorp's facility in Burlington, North Carolina. This award represents the federal government's...